AVITA Medical Inc
AVITA Medical Inc (RCEL) Straddle
RCEL straddle scan found 12 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 43.1%.
Read more
Trading a RCEL straddle lets you take a pure volatility position on AVITA Medical Inc without committing to a direction. AVITA Medical Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate RCEL straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on RCEL profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when AVITA Medical Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the RCEL straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older.
The company has a research collaboration with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells; and a research collaboration with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. was incorporated in 2000 and is based in Valencia, California.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the RCEL straddle is the cleanest expression of that view. Our scanner prices every RCEL straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a RCEL straddle into a catalyst or short a RCEL straddle to harvest decay, the options straddle setups that matter are all in one place.
| Jan 15, 2027 | 20.00 | $9.63 | 120 | 1% | 43.1% | $29.63 | $10.38 | 3 |
| Jan 15, 2027 | 7.50 | $4.93 | 120 | 1% | 32.5% | $12.43 | $2.58 | 82 |
| Apr 16, 2027 | 10.00 | $4.15 | 211 | 1% | 28.6% | $14.15 | $5.85 | 1 |
| Jan 15, 2027 | 15.00 | $5.85 | 120 | 1% | 28.1% | $20.85 | $9.15 | 0 |
| Oct 16, 2026 | 10.00 | $2.20 | 29 | 1% | 26.6% | $12.20 | $7.80 | 30 |
| Jan 15, 2027 | 12.50 | $4.08 | 120 | 1% | 25.6% | $16.58 | $8.43 | 1 |
| Nov 20, 2026 | 12.50 | $3.48 | 64 | 1% | 20.5% | $15.98 | $9.03 | 0 |
| Apr 16, 2027 | 15.00 | $7.48 | 211 | 1% | 20.3% | $22.48 | $7.53 | 0 |
| Jan 15, 2027 | 10.00 | $4.13 | 120 | 1% | 19.9% | $14.13 | $5.88 | 7 |
| Nov 20, 2026 | 10.00 | $3.33 | 64 | 1% | 19.4% | $13.33 | $6.68 | 0 |
As of September 17, 2026
Find the right straddle before volatility moves
Track RCEL straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.
Start your 14-day free trial→